MedPath

Edwards EVOQUE Eos MISCEND Study

Not Applicable
Active, not recruiting
Conditions
Mitral Valve Regurgitation (Degenerative or Functional)
Registration Number
NCT02718001
Lead Sponsor
Edwards Lifesciences
Brief Summary

Study to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system

Detailed Description

The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
123
Inclusion Criteria
  • Clinically significant, symptomatic mitral regurgitation
  • High risk for open-heart surgery
  • Meets anatomical criteria
Exclusion Criteria
  • Unsuitable anatomy
  • Patient is inoperable

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Composite of major adverse events30 days

Proportion of patients with major adverse events

Secondary Outcome Measures
NameTimeMethod
Clinical Success30 days

Proportion of patients with procedural success without major adverse events

Procedural SuccessDischarge or 7 days post-procedure, whichever occurs first

Proportion of patients with device success without significant paravalvular leak

NYHA functional class30 days, 6 Months, 12 Months, annual for five years

Number of patients with improvement in NYHA class

Reduction in MR grade30 days, 6 Months, 12 Months, annual for five years

Number of patients with reduction in MR grade from baseline

Device SuccessImmediately after procedure

Proportion of patients with device deployed as intended and delivery system successfully retrieved

Six minute walk test30 days, 6 Months, 12 Months, annual for five years

Increase in distance (m) from baseline

Trial Locations

Locations (19)

Sutter Mills-Peninsula

🇺🇸

Burlingame, California, United States

Cedars-Sinai Medical Center

🇺🇸

Los Angeles, California, United States

Kaiser Permanente San Francisco

🇺🇸

San Francisco, California, United States

Emory University Hospital/Emory University Hospital Midtown

🇺🇸

Atlanta, Georgia, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

St. Vincent Heart Center

🇺🇸

Indianapolis, Indiana, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

Morristown Medical Center

🇺🇸

Morristown, New Jersey, United States

St. Francis Hospital

🇺🇸

Roslyn, New York, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Scroll for more (9 remaining)
Sutter Mills-Peninsula
🇺🇸Burlingame, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.